+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Colchicine Market by Indication (Behçet's Disease, Familial Mediterranean Fever, Gout), Formulation (Injectable, Oral Capsule, Oral Tablet), Route, End User, Distribution Channel, Dosage - Global Forecast 2025-2030- Product Image
Colchicine Market by Indication (Behçet's Disease, Familial Mediterranean Fever, Gout), Formulation (Injectable, Oral Capsule, Oral Tablet), Route, End User, Distribution Channel, Dosage - Global Forecast 2025-2030- Product Image
Sale

Colchicine Market by Indication (Behçet's Disease, Familial Mediterranean Fever, Gout), Formulation (Injectable, Oral Capsule, Oral Tablet), Route, End User, Distribution Channel, Dosage - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 191 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5967649
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior executives seeking a clear understanding of emerging opportunities in the Colchicine market will find this report offers comprehensive analysis of market dynamics, shifting regulatory conditions, and actionable strategies, all structured to support resilient decision-making in a rapidly evolving therapeutic landscape.

Market Snapshot: Colchicine Market Overview

The Colchicine market grew from USD 1.58 billion in 2024 to USD 1.71 billion in 2025. It is expected to continue growing at a CAGR of 7.86%, reaching USD 2.49 billion by 2030. This growth is anchored in global demand for anti-inflammatory and autoimmune therapies, ongoing product development, broader clinical adoption, and the sector’s response to regulatory and supply chain shifts worldwide.

Scope & Segmentation of the Colchicine Market

This report provides a multi-layered analysis, enabling strategic insight into where market value is generated, major drivers of differentiation, and how internal and external forces influence outcomes.

  • Indication: Behçet’s Disease, Familial Mediterranean Fever, Gout, Pericarditis
  • Formulation: Injectable (Intramuscular, Intravenous), Oral Capsule, Oral Tablet (Extended Release, Standard Release)
  • Route: Oral, Parenteral (Intramuscular, Intravenous)
  • End User: Clinics, Home Care Settings, Hospitals
  • Distribution Channel: Hospital Pharmacy, Online Pharmacy (Direct-to-Consumer, Partner Platforms), Retail Pharmacy (Chain, Independent)
  • Dosage: High Dose (1.8 mg, 2.4 mg), Low Dose (0.3 mg, 0.6 mg), Standard Dose
  • Regional Coverage: Americas (United States: California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada; Mexico; Brazil; Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Leading Companies: Teva Pharmaceutical Industries Limited, Sandoz International GmbH, Viatris Inc., Sun Pharmaceutical Industries Limited, Lupin Limited, Dr. Reddy’s Laboratories Limited, Cipla Limited, Apotex Inc., Hetero Drugs Limited, Torrent Pharmaceuticals Limited

Key Takeaways for Senior Decision-Makers

  • Evolving formulation science has led to the introduction of advanced delivery options, improving consistency and patient compliance for inflammatory and autoimmune conditions.
  • Innovations in continuous manufacturing and quality-by-design approaches are enhancing production efficiency and reliability, addressing volume scalability and supply stability.
  • Streamlined regulatory pathways are accelerating new formulation approvals, encouraging manufacturers to invest in differentiated portfolio strategies and digital adherence tools.
  • Strategic partnerships, both with academic centers for translational research and regional distributors to enhance market access, are pivotal in overcoming localized barriers.
  • Segment-specific demand—varying by indication, delivery method, and route—shapes distinctive commercial opportunities, requiring tailored strategies for hospitals, home care, and retail settings.
  • Emerging digital health initiatives, including patient-centric adherence apps, are expanding long-term therapeutic management and data-driven dosing refinement.

Tariff Impact on Supply, Costs, and Trade

The 2025 adjustment of United States tariff schedules has altered cost structures along the Colchicine supply chain. Manufacturers now face rising input costs and more stringent customs protocols. Strategic responses include increasing domestic synthesis activities, dual-sourcing to mitigate risk, and renegotiating supplier contracts to share tariff burdens. Distribution and pricing are being recalibrated, with greater scrutiny of reimbursement decisions and access programs to ensure therapeutic continuity.

Research Methodology & Data Sources

This report uses a rigorous, multi-layered research approach. Insights derive from primary interviews with industry experts, clinicians, and regulators, combined with secondary analysis of peer-reviewed studies, regulatory filings, and clinical trial data. Quality checks and cross-source validation are embedded throughout the process.

Why This Report Matters to Your Strategy

  • Equips your leadership team with clear, actionable market intelligence to inform portfolio development, investment prioritization, and engagement with key stakeholders.
  • Supports supply chain and commercialization planning through deep visibility into region-specific dynamics, regulatory trends, and segmentation-based demand insights.

Conclusion

The Colchicine market is defined by dynamic therapeutic relevance, evolving technology application, and complex regulatory and trade environments. Strategic adaptation to these forces is key for sustained growth, resilience, and clinical value in the years ahead.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Rapid expansion of generic colchicine manufacturing capacity driving price erosion and market fragmentation
5.2. Development of once-daily extended release colchicine formulations to improve adherence in chronic gout management
5.3. Growing off-label use of colchicine in cardiovascular disease prevention following positive outcomes from COLCOT trial
5.4. Emergence of regulatory scrutiny on colchicine safety profiles leading to updated labeling and dosage guidelines
5.5. Integration of digital adherence monitoring and telemedicine platforms for real-time colchicine therapy management
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Colchicine Market, by Indication
8.1. Introduction
8.2. Behçet’s Disease
8.3. Familial Mediterranean Fever
8.4. Gout
8.5. Pericarditis
9. Colchicine Market, by Formulation
9.1. Introduction
9.2. Injectable
9.2.1. Intramuscular
9.2.2. Intravenous
9.3. Oral Capsule
9.4. Oral Tablet
9.4.1. Extended Release
9.4.2. Standard Release
10. Colchicine Market, by Route
10.1. Introduction
10.2. Oral
10.3. Parenteral
10.3.1. Intramuscular
10.3.2. Intravenous
11. Colchicine Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Home Care Settings
11.4. Hospitals
12. Colchicine Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.3. Online Pharmacy
12.3.1. Direct-to-Consumer
12.3.2. Partner Platforms
12.4. Retail Pharmacy
12.4.1. Chain
12.4.2. Independent
13. Colchicine Market, by Dosage
13.1. Introduction
13.2. High Dose
13.2.1. 1.8 mg
13.2.2. 2.4 mg
13.3. Low Dose
13.3.1. 0.3 mg
13.3.2. 0.6 mg
13.4. Standard Dose
14. Americas Colchicine Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Colchicine Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Colchicine Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Teva Pharmaceutical Industries Limited
17.3.2. Sandoz International GmbH
17.3.3. Viatris Inc.
17.3.4. Sun Pharmaceutical Industries Limited
17.3.5. Lupin Limited
17.3.6. Dr. Reddy's Laboratories Limited
17.3.7. Cipla Limited
17.3.8. Apotex Inc.
17.3.9. Hetero Drugs Limited
17.3.10. Torrent Pharmaceuticals Limited
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. COLCHICINE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL COLCHICINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL COLCHICINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL COLCHICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL COLCHICINE MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL COLCHICINE MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL COLCHICINE MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL COLCHICINE MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL COLCHICINE MARKET SIZE, BY ROUTE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL COLCHICINE MARKET SIZE, BY ROUTE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL COLCHICINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL COLCHICINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL COLCHICINE MARKET SIZE, BY DOSAGE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL COLCHICINE MARKET SIZE, BY DOSAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS COLCHICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS COLCHICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES COLCHICINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES COLCHICINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC COLCHICINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. COLCHICINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. COLCHICINE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. COLCHICINE MARKET: RESEARCHAI
FIGURE 28. COLCHICINE MARKET: RESEARCHSTATISTICS
FIGURE 29. COLCHICINE MARKET: RESEARCHCONTACTS
FIGURE 30. COLCHICINE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. COLCHICINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL COLCHICINE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL COLCHICINE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL COLCHICINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL COLCHICINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL COLCHICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL COLCHICINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL COLCHICINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL COLCHICINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL COLCHICINE MARKET SIZE, BY BEHÇET’S DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL COLCHICINE MARKET SIZE, BY BEHÇET’S DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL COLCHICINE MARKET SIZE, BY FAMILIAL MEDITERRANEAN FEVER, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL COLCHICINE MARKET SIZE, BY FAMILIAL MEDITERRANEAN FEVER, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL COLCHICINE MARKET SIZE, BY GOUT, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL COLCHICINE MARKET SIZE, BY GOUT, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL COLCHICINE MARKET SIZE, BY PERICARDITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL COLCHICINE MARKET SIZE, BY PERICARDITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL COLCHICINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL COLCHICINE MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL COLCHICINE MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL COLCHICINE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL COLCHICINE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL COLCHICINE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL COLCHICINE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL COLCHICINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL COLCHICINE MARKET SIZE, BY ORAL CAPSULE, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL COLCHICINE MARKET SIZE, BY ORAL CAPSULE, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL COLCHICINE MARKET SIZE, BY ORAL TABLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL COLCHICINE MARKET SIZE, BY ORAL TABLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL COLCHICINE MARKET SIZE, BY EXTENDED RELEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL COLCHICINE MARKET SIZE, BY EXTENDED RELEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL COLCHICINE MARKET SIZE, BY STANDARD RELEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL COLCHICINE MARKET SIZE, BY STANDARD RELEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL COLCHICINE MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL COLCHICINE MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL COLCHICINE MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL COLCHICINE MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL COLCHICINE MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL COLCHICINE MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL COLCHICINE MARKET SIZE, BY PARENTERAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL COLCHICINE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL COLCHICINE MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL COLCHICINE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL COLCHICINE MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL COLCHICINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL COLCHICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL COLCHICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL COLCHICINE MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL COLCHICINE MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL COLCHICINE MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL COLCHICINE MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL COLCHICINE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL COLCHICINE MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL COLCHICINE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL COLCHICINE MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL COLCHICINE MARKET SIZE, BY DIRECT-TO-CONSUMER, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL COLCHICINE MARKET SIZE, BY DIRECT-TO-CONSUMER, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL COLCHICINE MARKET SIZE, BY PARTNER PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL COLCHICINE MARKET SIZE, BY PARTNER PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL COLCHICINE MARKET SIZE, BY CHAIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL COLCHICINE MARKET SIZE, BY CHAIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL COLCHICINE MARKET SIZE, BY INDEPENDENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL COLCHICINE MARKET SIZE, BY INDEPENDENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL COLCHICINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL COLCHICINE MARKET SIZE, BY HIGH DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL COLCHICINE MARKET SIZE, BY HIGH DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL COLCHICINE MARKET SIZE, BY 1.8 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL COLCHICINE MARKET SIZE, BY 1.8 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL COLCHICINE MARKET SIZE, BY 2.4 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL COLCHICINE MARKET SIZE, BY 2.4 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL COLCHICINE MARKET SIZE, BY HIGH DOSE, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL COLCHICINE MARKET SIZE, BY LOW DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL COLCHICINE MARKET SIZE, BY LOW DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL COLCHICINE MARKET SIZE, BY 0.3 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL COLCHICINE MARKET SIZE, BY 0.3 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL COLCHICINE MARKET SIZE, BY 0.6 MG, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL COLCHICINE MARKET SIZE, BY 0.6 MG, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL COLCHICINE MARKET SIZE, BY LOW DOSE, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL COLCHICINE MARKET SIZE, BY STANDARD DOSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL COLCHICINE MARKET SIZE, BY STANDARD DOSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS COLCHICINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS COLCHICINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 101. AMERICAS COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 102. AMERICAS COLCHICINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS COLCHICINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS COLCHICINE MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS COLCHICINE MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS COLCHICINE MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS COLCHICINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS COLCHICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS COLCHICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS COLCHICINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS COLCHICINE MARKET SIZE, BY HIGH DOSE, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS COLCHICINE MARKET SIZE, BY LOW DOSE, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS COLCHICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS COLCHICINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 127. UNITED STATES COLCHICINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 128. UNITED STATES COLCHICINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES COLCHICINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES COLCHICINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES COLCHICINE MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES COLCHICINE MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES COLCHICINE MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES COLCHICINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES COLCHICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES COLCHICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES COLCHICINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES COLCHICINE MARKET SIZE, BY HIGH DOSE, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES COLCHICINE MARKET SIZE, BY LOW DOSE, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES COLCHICINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES COLCHICINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 155. CANADA COLCHICINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 156. CANADA COLCHICINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 157. CANADA COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 158. CANADA COLCHICINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 159. CANADA COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 160. CANADA COLCHICINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 161. CANADA COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 162. CANADA COLCHICINE MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 163. CANADA COLCHICINE MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 164. CANADA COLCHICINE MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 165. CANADA COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 166. CANADA COLCHICINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 167. CANADA COLCHICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. CANADA COLCHICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. CANADA COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 170. CANADA COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 171. CANADA COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 172. CANADA COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 173. CANADA COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 174. CANADA COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 175. CANADA COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 176. CANADA COLCHICINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 177. CANADA COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2024 (USD MILLION)
TABLE 178. CANADA COLCHICINE MARKET SIZE, BY HIGH DOSE, 2025-2030 (USD MILLION)
TABLE 179. CANADA COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2024 (USD MILLION)
TABLE 180. CANADA COLCHICINE MARKET SIZE, BY LOW DOSE, 2025-2030 (USD MILLION)
TABLE 181. MEXICO COLCHICINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 182. MEXICO COLCHICINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 183. MEXICO COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 184. MEXICO COLCHICINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 185. MEXICO COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 186. MEXICO COLCHICINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 187. MEXICO COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 188. MEXICO COLCHICINE MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 189. MEXICO COLCHICINE MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 190. MEXICO COLCHICINE MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 191. MEXICO COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 192. MEXICO COLCHICINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 193. MEXICO COLCHICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. MEXICO COLCHICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. MEXICO COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. MEXICO COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. MEXICO COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 198. MEXICO COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 199. MEXICO COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 200. MEXICO COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 201. MEXICO COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 202. MEXICO COLCHICINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 203. MEXICO COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2024 (USD MILLION)
TABLE 204. MEXICO COLCHICINE MARKET SIZE, BY HIGH DOSE, 2025-2030 (USD MILLION)
TABLE 205. MEXICO COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2024 (USD MILLION)
TABLE 206. MEXICO COLCHICINE MARKET SIZE, BY LOW DOSE, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL COLCHICINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL COLCHICINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL COLCHICINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL COLCHICINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL COLCHICINE MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL COLCHICINE MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL COLCHICINE MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL COLCHICINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL COLCHICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL COLCHICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 227. BRAZIL COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 228. BRAZIL COLCHICINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 229. BRAZIL COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2024 (USD MILLION)
TABLE 230. BRAZIL COLCHICINE MARKET SIZE, BY HIGH DOSE, 2025-2030 (USD MILLION)
TABLE 231. BRAZIL COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2024 (USD MILLION)
TABLE 232. BRAZIL COLCHICINE MARKET SIZE, BY LOW DOSE, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA COLCHICINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA COLCHICINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA COLCHICINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA COLCHICINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA COLCHICINE MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA COLCHICINE MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA COLCHICINE MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA COLCHICINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA COLCHICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA COLCHICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 251. ARGENTINA COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 252. ARGENTINA COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 253. ARGENTINA COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 254. ARGENTINA COLCHICINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 255. ARGENTINA COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2024 (USD MILLION)
TABLE 256. ARGENTINA COLCHICINE MARKET SIZE, BY HIGH DOSE, 2025-2030 (USD MILLION)
TABLE 257. ARGENTINA COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2024 (USD MILLION)
TABLE 258. ARGENTINA COLCHICINE MARKET SIZE, BY LOW DOSE, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 277. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 278. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 279. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 280. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 281. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2024 (USD MILLION)
TABLE 282. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY HIGH DOSE, 2025-2030 (USD MILLION)
TABLE 283. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2024 (USD MILLION)
TABLE 284. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY LOW DOSE, 2025-2030 (USD MILLION)
TABLE 285. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 286. EUROPE, MIDDLE EAST & AFRICA COLCHICINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM COLCHICINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM COLCHICINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM COLCHICINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM COLCHICINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM COLCHICINE MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM COLCHICINE MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 296. UNITED KINGDOM COLCHICINE MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 298. UNITED KINGDOM COLCHICINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM COLCHICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 300. UNITED KINGDOM COLCHICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 301. UNITED KINGDOM COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 302. UNITED KINGDOM COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 303. UNITED KINGDOM COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 304. UNITED KINGDOM COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 305. UNITED KINGDOM COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 306. UNITED KINGDOM COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 307. UNITED KINGDOM COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 308. UNITED KINGDOM COLCHICINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 309. UNITED KINGDOM COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2024 (USD MILLION)
TABLE 310. UNITED KINGDOM COLCHICINE MARKET SIZE, BY HIGH DOSE, 2025-2030 (USD MILLION)
TABLE 311. UNITED KINGDOM COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2024 (USD MILLION)
TABLE 312. UNITED KINGDOM COLCHICINE MARKET SIZE, BY LOW DOSE, 2025-2030 (USD MILLION)
TABLE 313. GERMANY COLCHICINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 314. GERMANY COLCHICINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 315. GERMANY COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 316. GERMANY COLCHICINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 317. GERMANY COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 318. GERMANY COLCHICINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 319. GERMANY COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 320. GERMANY COLCHICINE MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 321. GERMANY COLCHICINE MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 322. GERMANY COLCHICINE MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 323. GERMANY COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 324. GERMANY COLCHICINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 325. GERMANY COLCHICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 326. GERMANY COLCHICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 327. GERMANY COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 328. GERMANY COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 329. GERMANY COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 330. GERMANY COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 331. GERMANY COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 332. GERMANY COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 333. GERMANY COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 334. GERMANY COLCHICINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 335. GERMANY COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2024 (USD MILLION)
TABLE 336. GERMANY COLCHICINE MARKET SIZE, BY HIGH DOSE, 2025-2030 (USD MILLION)
TABLE 337. GERMANY COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2024 (USD MILLION)
TABLE 338. GERMANY COLCHICINE MARKET SIZE, BY LOW DOSE, 2025-2030 (USD MILLION)
TABLE 339. FRANCE COLCHICINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 340. FRANCE COLCHICINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 341. FRANCE COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 342. FRANCE COLCHICINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 343. FRANCE COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 344. FRANCE COLCHICINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 345. FRANCE COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 346. FRANCE COLCHICINE MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 347. FRANCE COLCHICINE MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 348. FRANCE COLCHICINE MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 349. FRANCE COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 350. FRANCE COLCHICINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 351. FRANCE COLCHICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 352. FRANCE COLCHICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 353. FRANCE COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 354. FRANCE COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 355. FRANCE COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 356. FRANCE COLCHICINE MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 357. FRANCE COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
TABLE 358. FRANCE COLCHICINE MARKET SIZE, BY RETAIL PHARMACY, 2025-2030 (USD MILLION)
TABLE 359. FRANCE COLCHICINE MARKET SIZE, BY DOSAGE, 2018-2024 (USD MILLION)
TABLE 360. FRANCE COLCHICINE MARKET SIZE, BY DOSAGE, 2025-2030 (USD MILLION)
TABLE 361. FRANCE COLCHICINE MARKET SIZE, BY HIGH DOSE, 2018-2024 (USD MILLION)
TABLE 362. FRANCE COLCHICINE MARKET SIZE, BY HIGH DOSE, 2025-2030 (USD MILLION)
TABLE 363. FRANCE COLCHICINE MARKET SIZE, BY LOW DOSE, 2018-2024 (USD MILLION)
TABLE 364. FRANCE COLCHICINE MARKET SIZE, BY LOW DOSE, 2025-2030 (USD MILLION)
TABLE 365. RUSSIA COLCHICINE MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 366. RUSSIA COLCHICINE MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 367. RUSSIA COLCHICINE MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 368. RUSSIA COLCHICINE MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 369. RUSSIA COLCHICINE MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 370. RUSSIA COLCHICINE MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 371. RUSSIA COLCHICINE MARKET SIZE, BY ORAL TABLET, 2018-2024 (USD MILLION)
TABLE 372. RUSSIA COLCHICINE MARKET SIZE, BY ORAL TABLET, 2025-2030 (USD MILLION)
TABLE 373. RUSSIA COLCHICINE MARKET SIZE, BY ROUTE, 2018-2024 (USD MILLION)
TABLE 374. RUSSIA COLCHICINE MARKET SIZE, BY ROUTE, 2025-2030 (USD MILLION)
TABLE 375. RUSSIA COLCHICINE MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 376. RUSSIA COLCHICINE MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 377. RUSSIA COLCHICINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 378. RUSSIA COLCHICINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 379. RUSSIA COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 380. RUSSIA COLCHICINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 381. RUSSIA COLCHICINE MARKET

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Colchicine market report include:
  • Teva Pharmaceutical Industries Limited
  • Sandoz International GmbH
  • Viatris Inc.
  • Sun Pharmaceutical Industries Limited
  • Lupin Limited
  • Dr. Reddy's Laboratories Limited
  • Cipla Limited
  • Apotex Inc.
  • Hetero Drugs Limited
  • Torrent Pharmaceuticals Limited

Table Information

Report AttributeDetails
No. of Pages191
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 1.71 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.49 Billion
Compound Annual Growth Rate7.8%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Colchicine Tablets Market by Product Type (Brand, Generic), Dosage Strength (0.5 Mg, 0.6 Mg, 1 Mg), Route Of Administration, Application, End User, Distribution Channel - Global Forecast 2025-2030 - Product Image

Colchicine Tablets Market by Product Type (Brand, Generic), Dosage Strength (0.5 Mg, 0.6 Mg, 1 Mg), Route Of Administration, Application, End User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 182 Pages
  • Global
From
2025 Colchicine Market Outlook Report: Industry Size, Market Shares Data, Insights, Growth Trends, Opportunities, Competition 2024 to 2032 - Product Image

2025 Colchicine Market Outlook Report: Industry Size, Market Shares Data, Insights, Growth Trends, Opportunities, Competition 2024 to 2032

  • Report
  • 144 Pages
  • Global
From
Colchicine (CAS 64-86-8) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Colchicine (CAS 64-86-8) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Colchicine Salicylate (CAS 8013-62-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029 - Product Image

Colchicine Salicylate (CAS 8013-62-5) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029

  • Report
  • 50 Pages
  • Global
From
Pericarditis Drugs - Global Strategic Business Report - Product Image

Pericarditis Drugs - Global Strategic Business Report

  • Report
  • 289 Pages
  • Global
From

About the Colchicine Market

Colchicine is a medication used to treat and prevent gout and other inflammatory conditions. It is a member of the cardiovascular drug class, which includes drugs used to treat and prevent heart and blood vessel diseases. Colchicine works by reducing inflammation and swelling, and is often used to treat acute gout attacks. It is also used to treat familial Mediterranean fever, pericarditis, and Behcet's disease. Colchicine is available in both oral and injectable forms, and is typically taken once or twice a day. Common side effects include nausea, vomiting, and diarrhea. Serious side effects include liver damage, kidney failure, and bone marrow suppression. The colchicine market is highly competitive, with many generic and branded products available. Companies in the market include Mylan, Teva Pharmaceuticals, Sandoz, and Sun Pharmaceuticals. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.